Charles David Pauza
CIK: 0002018150
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Traws Pharma, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 9, 2026TRAW
Traws Pharma, Inc.
Award(A)DirectStock Option (right to buy)
97K shares- - Mar 8, 2026TRAW
Traws Pharma, Inc.
Award(A)DirectStock Option (right to buy)
118.4K shares- - Dec 12, 2025TRAW
Traws Pharma, Inc.
Award(A)Direct18.5K shares- - Oct 12, 2025TRAW
Traws Pharma, Inc.
Award(A)DirectStock Option (right to purchase)
32.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 9, 2026 | TRAW Traws Pharma, Inc. | Award(A) Stock Option (right to buy) | 97,000 | - | - | Direct |
| Mar 8, 2026 | TRAW Traws Pharma, Inc. | Award(A) Stock Option (right to buy) | 118,367 | - | - | Direct |
| Dec 12, 2025 | TRAW Traws Pharma, Inc. | Award(A) | 18,471 | - | - | Direct |
| Oct 12, 2025 | TRAW Traws Pharma, Inc. | Award(A) Stock Option (right to purchase) | 32,406 | - | - | Direct |
1-4 of 4 transactions
About Pauza Charles David
Pauza Charles David (SEC CIK 0002018150) files insider reports with the SEC as Chief Science Officer Virology of Traws Pharma, Inc. (TRAW).
Signal8 holds 4 ownership filings by Pauza Charles David, all Form 4s, filed between Oct 15, 2025 and Jul 16, 2026. Those filings report 4 transactions, from Oct 12, 2025 to Jul 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Pauza Charles David's filings is in NEWTOWN, PA.
Recent filings by Pauza Charles David
Other insiders filing for Traws Pharma, Inc. (TRAW)
- CAUTREELS WERNER, Director
- Savchuk Nikolay, Chief Operating Officer
- STOVER JACK E, Director
- Dukes Iain D., Chief Executive Officer
- Redfield Robert, Chief Medical Officer
- Parker Charles Nolan, Chief Financial Officer